Letter/Comment
The latest advocacy letters and comments from the American Hospital Association.
The Honorable Chiquita Brooks-LaSure
Administrator
Centers for Medicare & Medicaid Services
200 Independence Avenue, S.W., Room 445-G
Washington, DC 20201
Dear Administrator Brooks-LaSure:
In a letter to Representative Lauren Underwood, the AHA expresses support for the Child Suicide Prevention and Lethal Means Safety Act.
The Honorable Chiquita Brooks-LaSure
Administrator
Centers for Medicare & Medicaid Services
Hubert H. Humphrey Building
200 Independence Avenue, S.W., Room 445-G
Washington, DC 20201
RE: Patient Protection and Affordable Care Act; Updating Payment Parameters, Section 1332 Waiver Implementing…
The AHA tells Senate leaders it strongly opposes “any attempt to take away previously-appropriated funding for hospitals and health systems, physicians, nurses and other health care providers providing heroic care during a global pandemic.”
The AHA tells Senate leaders it strongly opposes proposals to rescind emergency funds from the Provider Relief Fund to offset the costs of an infrastructure proposal.
Congress should not extend Medicare sequestration to help pay for the bipartisan infrastructure framework because health care providers cannot sustain additional Medicare cuts and Medicare funds should not be used to pay for non-health care programs, the AHA, American Medical Association, American…
In a letter to Representatives Robin L. Kelly and Larry Bucshon, the AHA express support for H.R. 4387, the Maternal Health Quality Improvement Act.
In a letter to the Centers for Medicare & Medicaid Services, AHA expresses continued concerns about audit determinations denying hospitals a “mid-build exception” to the site-neutral payment policy and urged the agency to extend by at least 180 days the July 18 and Sept. 16 deadlines for…
The AHA expresses support for the Protecting Rural Telehealth Access Act (S. 1988),
Letter the AHA sent to Senators Grassley and Durbin in support of S. 2304, Drug-Price Transparency for Consumers Act of 2021. The bill will allow HHS to require the disclosure of drug pricing information in direct-to-consumer (DTC) advertising.